Abionic wins international Local to Global Award15.04.2013 10:20
Recently, PwC's Accelerator held its third "Local to Global" Expo in Luxembourg, attended by 23 high-tech companies from Europe, North America and Russia. The objective of this event was to provide an overview of what European high-potential companies need to expand while bringing them expertise, business networks and fundraising solutions. The day ended with the Local to Global award ceremony.
The 23 participating high-growth companies presented their disruptive technologies and innovative value proposition to an audience of over 200 potential business partners (i.e. institutional investors, multinationals and academics).
"The latest studies conducted in Europe have confirmed two major challenges - investors lack qualitative projects and entrepreneurs look for smart financial solutions. We've organised the third 'local to global' Expo to bridge the gap between them," said Laurent Probst, partner, PwC Luxembourg.
In his speech about the challenges and opportunities for both the funds industry and companies, Richard Pelly, CEO of the European Investment Fund (EIF) said: "Capital investment is (re)emerging, bringing new models and new teams."
According to him, European and national public initiatives on the one side and the involvement of private investors on the other side are the right combination to create a favourable environment for the economic development of companies.
Finally, Carlos Ramón, a recognised expert in globalisation, moderated a roundtable which brought together representatives of large funds including Eurosia, Bertelsmann Digital Media, Texas Pacific Group, Zouk Capital and Iris Capital. Together they tackled the essential topic of the mid and long-term evolution of the relations between investors and entrepreneurs.
The day ended with the Local to Global award ceremony, in which the investors' audience voted during the course of the day.
The Best Elevator Pitch prize, which goes to the best presentation, was awarded to Abionic by Loïc Kubitza, Corporate Finance director, PwC Luxembourg. Abionic develops and sells diagnostic device that provides user-friendly allergy diagnoses. The company plans to commercially launch its system in the first quarter of 2014.
Abionic was incorporated as Swiss SA (Société Anonyme) in September 2010 and has its headquarters based in Lausanne, canton of Vaud, Switzerland. The company is positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to supply physicians with a novel diagnostic tool and thereby providing patients with personal allergy profiles. Abionic aims to become an important international player in the field of personalized allergy detection. The company won the Award of the W. A. de Vigier Foundation in 2011.